What to Expect From Apple’s Health Monitoring in the Future

3 minute read
| Analysis

Apple is emerging as a key player in health monitoring. Here’s how we can expect the technology to evolve over the next few years. Here’s how I think the technology ill evolve over time.

ECG app on Apple Watch Series 4

Apple Watch Series 4 ECG feature  Image credit: Apple

1. Early Phase. First we had personal pulse and ECG monitoring. Then blood glucose monitoring will likely come next. This could be a special Apple Watch band or a device attached to the hand. There is already an FDA approved device for Continuous Glucose Monitoring (CGM) called Eversense. However….

These systems have been designed to monitor glucose by using a tiny sensor that’s inserted under the skin on the arm or abdomen and is attached to a monitor.

Apple will want to be involved in this next step, but it may be waiting for non-invasive technology to mature. For example, the glucose level in sweat is related to the glucose levels in blood.

Keeping organized health records is key. Image credit: Apple

2. Health Records. The next step is the organization of personal health care data. Apple has a description of that process on the iPhone. This can start to get scary for some customers, but we trust Apple with a lot of personal data already. Here’s Apple description.

When health record data is transferred from a healthcare institution to the Health app, it is encrypted and does not traverse Apple’s network. When a user’s iPhone is locked with a passcode, Touch ID, or Face ID, their health data in the Health app is encrypted on-device. If a user chooses to sync their health data with iCloud, it is encrypted while in transit and at rest.

A challenge for some people here is getting everything set up on the iPhone, organized and properly communicated.

3. Clinical Trials. Apple’s ResearchKit is just the beginning of the collection of group data that will help researchers better understand diseases. For example, via Apple:

Since its launch in 2015, the mPower app has enrolled over 10,000 participants, making it the largest Parkinson’s study in history — with 93 percent of participants never having taken part in any kind of research before. The app helps researchers better understand Parkinson’s disease by using the gyroscope and other iPhone features to measure dexterity, balance, gait, and memory. Researchers have gained greater insight into the factors that make symptoms better or worse, such as sleep, exercise, and mood.

Woman consulting with doctor remotely.

Remote medicine tech will become mainstream.

4. Remote Medicine. Doctors are already doing this on a small scale in remote locations where there are few physicians and travel is difficult. The practice of remote medicine will likely expand so that patients can contact doctors on the internet and provide realtime data of various medical parameters. Here’s a forecast: “What does the future of remote patient monitoring look like? Abbott executive Robert Ford weighs in.” For example:

Our CardioMEMS HF System… is another example of an easy-to-use wireless technology for remotely monitoring the heart’s performance, specifically pressure in the pulmonary artery. The device is implanted directly into the pulmonary artery through a minimally invasive procedure. It transmits information wirelessly to the physician, who can adjust the treatment plan if needed, even before patients feel symptoms and without requiring follow-up appointments or hospitalizations. The CardioMEMS HF System, when used by clinicians to manage heart failure, has been proven to significantly reduce heart failure hospital admissions.

5. Blood Chemistry. As sensors and blood chemistry laboratories become more and more miniaturized, it will be possible to embed blood chemistry analyzers in the bloodstream and get instant, evolving data on key parameters via the iPhone and/or Apple Watch. Some will be common to all patients, such as liver and kidney functions, and some values will be for specific conditions a patient may have.

This information will be uploaded to a physician, but also used by the patient in realtime to dictate when to take medications, more precisely, or even what to eat. To that end, the food industry may even develop products, driven by health data, that can customize the nutritional profile of locally prepared foods.

Apple’s Challenge

Apple faces several challenge in this field. There are many players. All want a piece of the technology and the ensuing money. If history is a guide, key players will try to go their on way and dominate the market. Other players, perhaps even governments, will lobby for access as the data becomes ever more valuable.

Just how Apple fits it, leverages its stance on privacy, and both works with and competes against other involved companies will determine whether Apple becomes a pioneer that fades over time or else becomes the leader in this space with evolving hardware, technology, and consumer favor.

2
Leave a Reply

Please Login to comment
2 Comment threads
0 Thread replies
0 Followers
 
Most reacted comment
Hottest comment thread
2 Comment authors
aardmanwab95 Recent comment authors

This site uses Akismet to reduce spam. Learn how your comment data is processed.

  Subscribe  
newest oldest most voted
Notify of
aardman
Member
aardman

I view Apple’ s health care projects as the sleeper that Apple stock watchers are completely overlooking. Right now, there doesn’t seem to be any iPhone-level blockbuster products in the horizon but the nature of ground-breaking products and technology is that they aren’t groundbreaking if most people saw them coming. I am sure that the technologies and medical science will eventually come together and when it does, Apple is well positioned to take advantage of the opportunity. The number one reason: privacy. No one else out there is as trusted on user privacy. It’s skating to where the puck is… Read more »

wab95
Member
wab95

John: This is an excellent walk-through of both the specific steps and activities with which Apple is/can/should be involved, as well as potential third party partners, in providing healthcare specific products and services. This, as noted elsewhere, is already paying dividends in lives saved, even in Apple’s earliest phase and and simplest product iteration. Inevitably, if these products are popularly adopted, as signs indicate they will be, Apple will come under pressure to do two things, driven in no small measure by their own liability exposure: 1) Move beyond FDA and EMA cleared to approved technologies. They may be able… Read more »